Ayyan Investment Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Ayyan Investment.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 14.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
More Unpleasant Surprises Could Be In Store For Ayyan Investment Company's (TADAWUL:2140) Shares After Tumbling 29%
Apr 01
Ayyan Investment Company's (TADAWUL:2140) Business Is Trailing The Industry But Its Shares Aren't
Jan 19Can Ayyan Investment (TADAWUL:2140) Continue To Grow Its Returns On Capital?
Mar 15The Ayyan Investment (TADAWUL:2140) Share Price Has Gained 68% And Shareholders Are Hoping For More
Jan 30With EPS Growth And More, Ayyan Investment (TADAWUL:2140) Is Interesting
Jan 04We're Not Counting On Ayyan Investment (TADAWUL:2140) To Sustain Its Statutory Profitability
Dec 08
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ayyan Investment has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2023 | 296 | -174 | -100 | 6 | N/A |
| 6/30/2023 | 270 | -134 | -136 | -12 | N/A |
| 3/31/2023 | 260 | -105 | -196 | -56 | N/A |
| 12/31/2022 | 266 | -45 | -186 | -39 | N/A |
| 9/30/2022 | 270 | -22 | -149 | 8 | N/A |
| 6/30/2022 | 268 | -2 | -132 | 44 | N/A |
| 3/31/2022 | 273 | 10 | -92 | 78 | N/A |
| 12/31/2021 | 270 | 4 | -129 | 48 | N/A |
| 9/30/2021 | 273 | 10 | -140 | 14 | N/A |
| 6/30/2021 | 274 | 12 | -136 | -11 | N/A |
| 3/31/2021 | 265 | 16 | -75 | 46 | N/A |
| 12/31/2020 | 255 | 24 | -34 | 58 | N/A |
| 9/30/2020 | 260 | 19 | 19 | 73 | N/A |
| 6/30/2020 | 254 | 15 | 52 | 85 | N/A |
| 3/31/2020 | 251 | 13 | -3 | 17 | N/A |
| 12/31/2019 | 246 | -1 | -1 | 16 | N/A |
| 9/30/2019 | 238 | 14 | 0 | 19 | N/A |
| 6/30/2019 | 235 | 13 | -14 | 6 | N/A |
| 3/31/2019 | 230 | 11 | -4 | 17 | N/A |
| 12/31/2018 | 226 | 7 | -12 | 11 | N/A |
| 9/30/2018 | 217 | -11 | -26 | -2 | N/A |
| 6/30/2018 | 210 | -15 | -19 | 4 | N/A |
| 3/31/2018 | 211 | -13 | -27 | -2 | N/A |
| 12/31/2017 | 209 | -9 | -18 | 6 | N/A |
| 9/30/2017 | 203 | -14 | -32 | -11 | N/A |
| 6/30/2017 | 199 | -15 | N/A | -15 | N/A |
| 3/31/2017 | 193 | -28 | N/A | 0 | N/A |
| 12/31/2016 | 192 | -32 | N/A | -2 | N/A |
| 9/30/2016 | 195 | -18 | N/A | 24 | N/A |
| 6/30/2016 | 193 | -3 | N/A | 19 | N/A |
| 3/31/2016 | 191 | 45 | N/A | 3 | N/A |
| 12/31/2015 | 151 | 52 | N/A | 14 | N/A |
| 9/30/2015 | 103 | 26 | N/A | -22 | N/A |
| 6/30/2015 | 61 | 34 | N/A | 7 | N/A |
| 3/31/2015 | 16 | -5 | N/A | 1 | N/A |
| 12/31/2014 | 7 | -4 | N/A | -14 | N/A |
| 9/30/2014 | 8 | 33 | N/A | 7 | N/A |
| 6/30/2014 | 12 | 15 | N/A | -19 | N/A |
| 3/31/2014 | 17 | 21 | N/A | -15 | N/A |
| 12/31/2013 | 21 | 16 | N/A | -14 | N/A |
| 9/30/2013 | 18 | 2 | N/A | -9 | N/A |
| 6/30/2013 | 14 | -1 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2140's forecast earnings growth is above the savings rate (14%).
Earnings vs Market: Insufficient data to determine if 2140's earnings are forecast to grow faster than the SA market
High Growth Earnings: Insufficient data to determine if 2140's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 2140's revenue is forecast to grow faster than the SA market.
High Growth Revenue: Insufficient data to determine if 2140's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2140's Return on Equity is forecast to be high in 3 years time